Key Takeaways SYK's Q4 performance is expected to reflect stable procedure volumes and healthy hospital capital spending.SYK likely saw broad-based demand across Orthopedics, and MedSurg and Neurotechnology, aided by new launches.SYK's margins likely gained from mix and efficiency, partly offset by tariff pressure and higher interest.Stryker Corporation (SYK) is scheduled to release fourth-quarter 2025 results on Jan. 29, after market close. In the last reported quarter, the company delivered an earnings su ...